Agilent Obtains U.S. FDA Approval for GenetiSure Dx Postnatal Assay

World News: . []

Agilent Technologies Inc NYSE A has announced that it has obtained 510k clearance from the US Food and Drug Administration FDA for the GenetiSure Dx Postnatal Assay its first comparative genomic hybridization CGH) as...

More news and information about Agilent Technologies Inc.

Published By:

Business Wire: 16:00 GMT Wednesday 13th September 2017

Published: .

Search for other references to "agilent" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us

Advertising on SPi News: Information For Advertisers